全文获取类型
收费全文 | 113篇 |
免费 | 6篇 |
出版年
2023年 | 2篇 |
2020年 | 3篇 |
2019年 | 8篇 |
2018年 | 1篇 |
2017年 | 3篇 |
2016年 | 2篇 |
2015年 | 9篇 |
2014年 | 8篇 |
2013年 | 10篇 |
2012年 | 7篇 |
2011年 | 9篇 |
2010年 | 3篇 |
2009年 | 4篇 |
2008年 | 5篇 |
2007年 | 6篇 |
2006年 | 4篇 |
2005年 | 2篇 |
2004年 | 2篇 |
2003年 | 3篇 |
2002年 | 2篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1988年 | 3篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1971年 | 1篇 |
1966年 | 1篇 |
1960年 | 2篇 |
1927年 | 1篇 |
排序方式: 共有119条查询结果,搜索用时 343 毫秒
71.
72.
Natalia Bailon-Moscoso Gabriela González-Arévalo Gabriela Velásquez-Rojas Omar Malagon Giovanni Vidari Alejandro Zentella-Dehesa Edward A. Ratovitski Patricia Ostrosky-Wegman 《PloS one》2015,10(8)
Accumulating evidence supports the idea that secondary metabolites obtained from medicinal plants (phytometabolites) may be important contributors in the development of new chemotherapeutic agents to reduce the occurrence or recurrence of cancer. Our study focused on Dehydroleucodine (DhL), a sesquiterpene found in the provinces of Loja and Zamora-Chinchipe. In this study, we showed that DhL displayed cytostatic and cytotoxic activities on the human cerebral astrocytoma D384 cell line. With lactone isolated from Gynoxys verrucosa Wedd, a medicinal plant from Ecuador, we found that DhL induced cell death in D384 cells by triggering cell cycle arrest and inducing apoptosis and DNA damage. We further found that the cell death resulted in the increased expression of CDKN1A and BAX proteins. A marked induction of the levels of total TP73 and phosphorylated TP53, TP73, and γ-H2AX proteins was observed in D384 cells exposed to DhL, but no increase in total TP53 levels was detected. Overall these studies demonstrated the marked effect of DhL on the diminished survival of human astrocytoma cells through the induced expression of TP73 and phosphorylation of TP73 and TP53, suggesting their key roles in the tumor cell response to DhL treatment. 相似文献
73.
Patricia Peña-Orihuela Antonio Camargo Oriol Alberto Rangel-Zuñiga Pablo Perez-Martinez Cristina Cruz-Teno Javier Delgado-Lista Elena M. Yubero-Serrano Juan A. Paniagua Francisco J. Tinahones Maria M. Malagon Helen M. Roche Francisco Perez-Jimenez Jose Lopez-Miranda 《The Journal of nutritional biochemistry》2013,24(10):1717-1723
Metabolic syndrome (MetS) is associated with high oxidative stress, which is caused by an increased expression of NADPH-oxidase and a decreased expression of antioxidant enzymes in the adipose tissue. Our aim was to evaluate whether the quality and quantity of dietary fat can modify that process. A randomized, controlled trial conducted within the LIPGENE study assigned MetS patients to one of four diets for 12 wk each: (i) high-saturated fatty acid (HSFA), (ii) high-monounsaturated fatty acid (HMUFA), (iii) and (iv) two low-fat, high-complex carbohydrate diet supplemented with n-3 polyunsaturated fatty acids (LFHCC n3), or placebo (LFHCC). A fat challenge reflecting the same fatty acid composition as the original diets was conducted post-intervention. The intake of an HSFA meal induced a higher postprandial increase in gp91phox and p67phox mRNA levels than after the intake of HMUFA, LFHCC and LFHCC n-3 meals (all p-values < 0.05). The postprandial decrease in CAT, GPXs and TXNRD1 mRNA levels after the HSFA meal intake was higher than after the intake of HMUFA, LFHCC and LFHCC n-3 meals (all p-values < 0.05). The intake of an HSFA meal induced a higher postprandial increase in KEAP1 mRNA levels than after the consumption of the HMUFA (P = .007) and LFHCC n-3 (P = .001) meals. Our study demonstrated that monounsaturated fat consumption reduces oxidative stress as compared to saturated fat by inducing higher postprandial antioxidant response in adipose tissue, and thus, replacing SFA for MUFA may be an effective dietary strategy to reduce the oxidative stress in MetS patients and its pathophysiological consequences. 相似文献
74.
75.
76.
77.
Mait�� Montero-Hadjadje Salah Elias Laurence Chevalier Magalie Benard Yannick Tanguy Val��rie Turquier Ludovic Galas Laurent Yon Maria M. Malagon Azeddine Driouich St��phane Gasman Youssef Anouar 《The Journal of biological chemistry》2009,284(18):12420-12431
Chromogranin A (CgA) has been proposed to play a major role in the
formation of dense-core secretory granules (DCGs) in neuroendocrine cells.
Here, we took advantage of unique features of the frog CgA (fCgA) to assess
the role of this granin and its potential functional determinants in hormone
sorting during DCG biogenesis. Expression of fCgA in the constitutively
secreting COS-7 cells induced the formation of mobile vesicular structures,
which contained cotransfected peptide hormones. The fCgA and the hormones
coexpressed in the newly formed vesicles could be released in a regulated
manner. The N- and C-terminal regions of fCgA, which exhibit remarkable
sequence conservation with their mammalian counterparts were found to be
essential for the formation of the mobile DCG-like structures in COS-7 cells.
Expression of fCgA in the corticotrope AtT20 cells increased
pro-opiomelanocortin levels in DCGs, whereas the expression of N- and
C-terminal deletion mutants provoked retention of the hormone in the Golgi
area. Furthermore, fCgA, but not its truncated forms, promoted
pro-opiomelanocortin sorting to the regulated secretory pathway. These data
demonstrate that CgA has the intrinsic capacity to induce the formation of
mobile secretory granules and to promote the sorting and release of peptide
hormones. The conserved terminal peptides are instrumental for these
activities of CgA.Eukaryotic cells share the capacity to rapidly secrete proteins through the
constitutive secretory pathway. The fundamental feature of neuroendocrine and
endocrine cells is the occurrence of dense-core secretory granules
(DCGs),3
which are key cytoplasmic organelles responsible for secretion of hormones,
neuropeptides, and neurotransmitters through the regulated secretory pathway
(RSP). Storage at high concentrations of these secretory products is required
for their finely tuned release in response to extracellular stimulation
(1,
2). DCG biogenesis starts with
the budding of immature secretory granules (ISGs) from the
trans-Golgi network (TGN) through interactions between lipid rafts
and protein components, in a similar manner to constitutive vesicle budding
(2,
3). The ISG budding is followed
by a multistep maturation process to form the mature secretory granules,
including removal of the constitutive secretory proteins and lysosomal enzymes
inadvertently packaged into ISGs
(4).Despite increasing knowledge of the various steps of DCG formation, the
nature of the sorting signals for entry of proteins into the DCGs and the
molecular machinery required to generate secretory granules are not fully
elucidated (5,
6). Several recent studies
highlighted the role of members of the granin family, which may represent the
driving force for granulogenesis in the TGN
(2), although this notion has
been a matter of debate (7).
Granins are soluble acidic proteins widely distributed in endocrine and
neuroendocrine cells, which are characterized by the ability to aggregate at
acidic pH and a high Ca2+ environment
(8,
9). These conditions are found
in the lumen of the TGN allowing granins to aggregate in this compartment and
to be segregated from constitutively secreted proteins
(10,
11). The granin aggregates are
believed to associate directly or indirectly with lipid rafts at the TGN to
induce budding and formation of the ISGs. A prominent role of chromogranin A
(CgA) in the regulation of DCG formation in endocrine and neuroendocrine cells
has been proposed. Thus, depletion of CgA in PC12 cells led to a dramatic
decrease in the number of DCGs
(12), and exogenously
expressed CgA in these depleted PC12 cells, as in DCG-deficient endocrine A35C
and 6T3 cells, restored DCG biogenesis
(12,
13). Besides, expression of
granins in non-endocrine, constitutively secreting cells such as CV-1, NIH3T3,
or COS-7 cells provoked the formation of DCG-like structures that release
their content in response to Ca2+ influx
(12,
14,
15). Further investigations
performed in CgA null mice and transgenic mice expressing antisense RNA
against CgA also revealed a reduction in the number of DCGs in chromaffin
cells that was associated with an impairment of catecholamine storage, thus
demonstrating the crucial role of CgA in normal DCG biogenesis
(16,
17). In CgA knockout mice, the
introduction of the gene expressing human CgA restored the regulated secretory
phenotype (16). A different
CgA null mice strain exhibited no discernable effect on DCG formation, but
elevated catecholamine secretion
(18), proving that CgA
deficiency is associated with hormone storage impairment in neuroendocrine
cells in vivo, a finding that was confirmed in vitro
(19). The CgA-/-
mice strain generated by Hendy et al.
(18) exhibited a compensatory
overexpression of other granins, pointing to a possible overlap in granin
function in secretory granule biogenesis.We reported previously that the frog CgA (fCgA) gene is coordinately
regulated with the pro-opiomelanocortin (POMC) gene in the pituitary pars
intermedia during the neuroendocrine reflex of skin color change, which allows
amphibia to adapt to their environment through the release of POMC-derived
melanotropic peptides (20,
21). Sequence comparison of
fCgA with its mammalian orthologs revealed a high conservation of the N- and
C-terminal domains, and far less conservation of the central part of the
protein (Fig. 1A),
suggesting that these domains may play a role in DCG formation and hormone
release in various species (9,
20,
21). To assess the role of
fCgA and its conserved N- and C-terminal regions in hormone sorting, storage,
and secretion, we engineered different constructs that produce the native
unmodified (no tag added) protein and truncated forms lacking the conserved N-
and C-terminal domains, and we developed an antibody that specifically
recognizes the central region of fCgA. Using the constitutively secreting
COS-7 cells, which are devoid of DCGs, we could demonstrate for the first time
that CgA is essential for targeting peptide hormones to newly formed mobile
DCG-like structures. In the CgA-expressing AtT20 cells, which exhibit an only
moderate capacity to sort secretory proteins to the regulated pathway
(22), the granin plays a
pivotal role in the sorting and release of POMC. The conserved terminal
peptides of CgA are instrumental for these activities.Open in a separate windowFIGURE 1.Specificity of the antibody directed against frog CgA. A,
scheme depicting the structure of fCgA and showing the high conservation of
the terminal regions and the percentages of amino acid identity between frog
and human CgA sequences. The highly conserved peptide WE14 and dibasic
cleavage sites are also indicated. B, Western blot showing that the
antibody developed against fCgA recognized the protein and several processing
intermediates in frog but not rat pituitary extracts, whereas an antibody,
directed against the WE14 conserved peptide, detected CgA and its processing
products in both rat and frog pituitary extracts. C,
immunofluorescence analysis of frog pituitary and adrenal glands, and rat
adrenal gland using the antibodies against fCgA and WE14. cx, cortex;
DL, distal lobe; IL, intermediate lobe; and m,
medulla. Scale bars equal 10 μm. 相似文献
78.
79.
Annemarie MM Vlaar Tjerk de Nijs Marinus JPG van Kroonenburgh Werner H Mess Ania Winogrodzka Selma C Tromp Wim EJ Weber 《BMC neurology》2008,8(1):42
Background
Transcranial duplex sonography (TCD) of the substantia nigra has emerged as a promising, non-invasive tool to diagnose idiopathic Parkinson's disease (IPD). However, its diagnostic accuracy in patients with undefined parkinsonism remains to be determined. 相似文献80.